WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced that it has scheduled its second quarter 2022 financial results and corporate update for Thursday, August 4, 2022. The schedule for the press release and conference call/webcast are as follows:
• Q2/2022 Conference Call/Webcast: Thursday, August 4, 2022, at 8:45 a.m. ET
• Domestic Dial-In Number: (800) 715-9871
• International Dial-In Number: (646) 307-1963
• Conference ID Number: 5109143
A live webcast of the conference call can be accessed through the Investors section of Arbutus’ website at www.arbutusbio.com.
An archived webcast will be available on the Arbutus website after the event. Alternatively, you may access a replay of the conference call by calling (800) 770-2030 or (609) 800-9909, and reference conference ID: 5109143.
You May Also Be Interested In…
- Globus Medical Reports Second Quarter 2022 Results
- Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results
- Safeguard Scientifics to Release Second Quarter 2022 Financial Results
- Hill International Schedules Release of Second Quarter 2022 Financial Results
- StoneMor Inc. Announces Date of Conference Call for 2022 Second Quarter Financial Results
Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.